171 related articles for article (PubMed ID: 37935665)
21. Mutations affecting the actin regulator WD repeat-containing protein 1 lead to aberrant lymphoid immunity.
Pfajfer L; Mair NK; Jiménez-Heredia R; Genel F; Gulez N; Ardeniz Ö; Hoeger B; Bal SK; Madritsch C; Kalinichenko A; Chandra Ardy R; Gerçeker B; Rey-Barroso J; Ijspeert H; Tangye SG; Simonitsch-Klupp I; Huppa JB; van der Burg M; Dupré L; Boztug K
J Allergy Clin Immunol; 2018 Nov; 142(5):1589-1604.e11. PubMed ID: 29751004
[TBL] [Abstract][Full Text] [Related]
22. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
23. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
24. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
25. Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation.
Bell JB; Eckerdt F; Dhruv HD; Finlay D; Peng S; Kim S; Kroczynska B; Beauchamp EM; Alley K; Clymer J; Goldman S; Cheng SY; James CD; Nakano I; Horbinski C; Mazar AP; Vuori K; Kumthekar P; Raizer J; Berens ME; Platanias LC
Mol Cancer Res; 2018 Jan; 16(1):32-46. PubMed ID: 29042487
[TBL] [Abstract][Full Text] [Related]
26. A Novel Blood-Brain Barrier-Penetrating and Vascular-Targeting Chimeric Peptide Inhibits Glioma Angiogenesis.
Lu L; Wang L; Zhao L; Liao J; Zhao C; Xu X; Wang F; Zhang X
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240099
[TBL] [Abstract][Full Text] [Related]
27. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.
Canella A; Welker AM; Yoo JY; Xu J; Abas FS; Kesanakurti D; Nagarajan P; Beattie CE; Sulman EP; Liu J; Gumin J; Lang FF; Gurcan MN; Kaur B; Sampath D; Puduvalli VK
Clin Cancer Res; 2017 Oct; 23(20):6215-6226. PubMed ID: 28679777
[No Abstract] [Full Text] [Related]
29. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
[TBL] [Abstract][Full Text] [Related]
30. Quercetin induces MGMT
Wang W; Yuan X; Mu J; Zou Y; Xu L; Chen J; Zhu X; Li B; Zeng Z; Wu X; Yin Z; Wang Q
Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
32. AIP1/WDR1 supports mitotic cell rounding.
Fujibuchi T; Abe Y; Takeuchi T; Imai Y; Kamei Y; Murase R; Ueda N; Shigemoto K; Yamamoto H; Kito K
Biochem Biophys Res Commun; 2005 Feb; 327(1):268-75. PubMed ID: 15629458
[TBL] [Abstract][Full Text] [Related]
33. G9a promotes immune suppression by targeting the Fbxw7/Notch pathway in glioma stem cells.
Cao Y; Liu B; Cai L; Li Y; Huang Y; Zhou Y; Sun X; Yang W; Sun T
CNS Neurosci Ther; 2023 Sep; 29(9):2508-2521. PubMed ID: 36971192
[TBL] [Abstract][Full Text] [Related]
34. Trp-Asp (WD) Repeat Domain 1 Is Essential for Mouse Peri-implantation Development and Regulates Cofilin Phosphorylation.
Xiao Y; Ma H; Wan P; Qin D; Wang X; Zhang X; Xiang Y; Liu W; Chen J; Yi Z; Li L
J Biol Chem; 2017 Jan; 292(4):1438-1448. PubMed ID: 27994054
[TBL] [Abstract][Full Text] [Related]
35. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
[TBL] [Abstract][Full Text] [Related]
36. Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma.
Tao W; Chu C; Zhou W; Huang Z; Zhai K; Fang X; Huang Q; Zhang A; Wang X; Yu X; Huang H; Wu Q; Sloan AE; Yu JS; Li X; Stark GR; Rich JN; Bao S
Nat Commun; 2020 Jun; 11(1):3015. PubMed ID: 32541784
[TBL] [Abstract][Full Text] [Related]
37. Adipose‑derived stem cell‑mediated alphastatin targeting delivery system inhibits angiogenesis and tumor growth in glioma.
Liang C; Wei T; Zhang T; Niu C
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772382
[TBL] [Abstract][Full Text] [Related]
38. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
39. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
40. Novel facets of glioma invasion.
Fabian C; Han M; Bjerkvig R; Niclou SP
Int Rev Cell Mol Biol; 2021; 360():33-64. PubMed ID: 33962750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]